Deutsche Bank’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-27,587
| Closed | -$671K | – | 5800 |
|
|
2017
Q4 | $671K | Buy |
27,587
+7,187
| +35% | +$138K | ﹤0.01% | 3456 |
|
|
2017
Q3 | $375K | Sell |
20,400
-4,095
| -17% | -$70.9K | ﹤0.01% | 3560 |
|
|
2017
Q2 | $404K | Buy |
24,495
+22,659
| +1,234% | +$315K | ﹤0.01% | 3569 |
|
|
2017
Q1 | $25K | Sell |
1,836
-2,641
| -59% | -$42.4K | ﹤0.01% | 4451 |
|
|
2016
Q4 | $84K | Buy |
4,477
+3,239
| +262% | +$62.1K | ﹤0.01% | 4159 |
|
|
2016
Q3 | $27K | Buy |
1,238
+92
| +8% | +$1.73K | ﹤0.01% | 4448 |
|
|
2016
Q2 | $20K | Sell |
1,146
-257
| -18% | -$4.42K | ﹤0.01% | 4761 |
|
|
2016
Q1 | $24K | Buy |
1,403
+42
| +3% | +$679 | ﹤0.01% | 4591 |
|
|
2015
Q4 | $22K | Sell |
1,361
-160
| -11% | -$2.72K | ﹤0.01% | 4736 |
|
|
2015
Q3 | $27K | Buy |
1,521
+195
| +15% | +$4.34K | ﹤0.01% | 4690 |
|
|
2015
Q2 | $34K | Buy |
1,326
+1,319
| +18,843% | +$33.3K | ﹤0.01% | 4745 |
|
|
2015
Q1 | $0 | Buy |
+7
| New | +$151 | ﹤0.01% | 6294 |
|
Deutsche Bank's ENTL Position: Q1 2018 in Review
Deutsche Bank sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 27,587 shares — an estimated $671K sold.
Deutsche Bank first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $671K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.
- Deutsche Bank reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
- Deutsche Bank sold 27,587 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $671K.
- Deutsche Bank first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
- Deutsche Bank's Entellus Medical, Inc. Common Stock position peaked at $671K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.
Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.